Injectable Drug Delivery Devices Sector: Growth Drivers and Challenges
Growth Drivers
- Emergence of Self-Injectors
- Increasing Incidence of Chronic Diseases
Challenges
- Injuries & Infections Caused by Needles
- Increasing Use of Alternative Delivery Methods
Injectable Drug Delivery Devices Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
7.1% |
|
Base Year Market Size (2024) |
USD 123.2 billion |
|
Forecast Year Market Size (2037) |
USD 300.52 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of injectable drug delivery devices is assessed at USD 130.64 billion.
Injectable Drug Delivery Devices Market size was over USD 123.2 billion in 2024 and is projected to reach USD 300.52 billion by 2037, growing at around 7.1% CAGR during the forecast period i.e., between 2025-2037.
Asia Pacific industry is set to dominate majority revenue share by 2037, propelled by increasing incidence of chronic disorders in the region.
The major players in the market are Baxter International Inc., Eli Lilly and Company, West Pharmaceutical Services Inc., Pfizer Inc., Schott AG, and others.
